scispace - formally typeset
Q

Qiurong Ye

Researcher at Central South University

Publications -  14
Citations -  696

Qiurong Ye is an academic researcher from Central South University. The author has contributed to research in topics: Inflammation & Lactoferrin. The author has an hindex of 12, co-authored 13 publications receiving 582 citations. Previous affiliations of Qiurong Ye include Chinese Ministry of Education.

Papers
More filters
Journal ArticleDOI

miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma

TL;DR: The present study found that miR-216b was downregulated in nasopharyngeal carcinoma (NPC) cell lines and specimens and demonstrated that it can bind to the 3′ untranslated region (UTR) of KRAS and inhibit expression of the KRAS protein.
Journal ArticleDOI

Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway.

TL;DR: EBV miR-BART6-3p inhibited the EBV-triggered IFN-β response and facilitated EBV infection through targeting the 3′UTR of RIG-I mRNA, providing new insights into the mechanism underlying the strategies employed by EBV to evade immune surveillance.
Journal ArticleDOI

miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma

TL;DR: Zhang et al. as mentioned in this paper reported that miR-214 mimics significantly suppressed LTL mRNA and protein expression levels in NPC cells, and the expression level was negatively correlated with LTL down-regulation.
Journal ArticleDOI

Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms.

TL;DR: It is revealed that LTF can suppress 3-phosphoinositide-dependentprotein kinase 1 expression via the mitogen-activated protein kinase/c-Jun pathway and thus repress AKT signaling, leading to inhibition of NPC tumorigenesis and suggests that both LTF and AKT signaled merit further study in the field of NPC research.
Journal ArticleDOI

Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice.

TL;DR: It is reported that administration of a neutralizing anti-S100a9 antibody significantly ameliorated dextran sulfate sodium (DSS)-induced colitis and accompanied by diminished cellular infiltrate of innate immunity cells and production of pro-inflammatory cytokines and the risk for developing CAC is decreased.